Literature DB >> 19404231

Intrauterine growth retardation (IUGR): epidemiology and etiology.

Agustín Romo1, Raquel Carceller, Javier Tobajas.   

Abstract

Intrauterine growth retardation (IUGR) is mainly due to a pathologic slow-down in the fetal growth pace, resulting in a fetus that is unable to reach its growth potential. IUGR frequency will vary depending on the discrimination criteria adopted. It is extremely important to use local or national fetal growth graphs in order to avoid some confounding factors. IUGR incidence in newborns would be between 3% and 7% of the total population. In our experience it is 5.13% a figure similar to the one obtained by other authors but with a progressively higher incidence during the last decade. There are multiple maternal factors that can generally be grouped into constitutional and general factors given that they affect age, weight, race, maternal cardiac volume, etc, socioeconomic factors with key incidence in the mother's nutrition level, where a poor maternal nutrition level would be the key factor in this group. We have evaluated multiple factors as possible contributors to the IUGR risk: race, parents' age, mother's height (cm), mother's birth weight and before pregnancy (kg), ponderal gain and blood pressure during pregnancy, and previous SGA newborns. Socioeconomic factors like social class, parents' profession, habitual residence, salary, immigration, and diet were also evaluated. We also included variables such as total daily working time and time mothers spent standing up, daily sleeping time (hrs), stress self-perception test at work and primiparity age. Toxic factors during pregnancy: tobacco (active and passive), alcohol, drugs and coffee consumption. Fetal or utero-placental factors were considered. In our study, the most significant etiologic factors were: Active and passive tobacco consuming, mother's stress level, increase of total months worked during pregnancy, total daily working hours and time mothers spent standing up and finally, the parent's height. Our data support the main objective of reducing the incidence of SGA newborns after IUGR by fighting against tobacco from all fields, including the passive smoking habit, and improving the laboral conditions of the pregnant mother, lowering the number of daily hours worked, the physical activity and trying to avoid and to cope with stressful situations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404231

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  87 in total

1.  Ovine surgical model of uterine space restriction: interactive effects of uterine anomalies and multifetal gestations on fetal and placental growth.

Authors:  Katie M Meyer; Jill M Koch; Jayanth Ramadoss; Pamela J Kling; Ronald R Magness
Journal:  Biol Reprod       Date:  2010-06-23       Impact factor: 4.285

Review 2.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

3.  Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats.

Authors:  Vijayakumar Chinnathambi; Amar S More; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2014-05-22       Impact factor: 4.285

4.  Assessing the effectiveness of vehicle emission regulations on improving perinatal health: a population-based accountability study.

Authors:  Mary D Willis; Elaine L Hill; Molly L Kile; Susan Carozza; Perry Hystad
Journal:  Int J Epidemiol       Date:  2021-01-23       Impact factor: 7.196

Review 5.  Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.

Authors:  Stephanie A Blankenship; Kristine E Brown; Laura E Simon; Molly J Stout; Methodius G Tuuli
Journal:  Am J Obstet Gynecol MFM       Date:  2020-08-17

Review 6.  Complications during pregnancy and fetal development: implications for the occurrence of chronic kidney disease.

Authors:  Ashley D Newsome; Gwendolyn K Davis; Norma B Ojeda; Barbara T Alexander
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-02-16

7.  Adverse Placental Perfusion and Pregnancy Outcomes in a New Nonhuman Primate Model of Gestational Protein Restriction.

Authors:  Victoria H J Roberts; Jamie O Lo; Katherine S Lewandowski; Peter Blundell; Kevin L Grove; Christopher D Kroenke; Elinor L Sullivan; Charles T Roberts; Antonio E Frias
Journal:  Reprod Sci       Date:  2017-04-26       Impact factor: 3.060

Review 8.  Effects of prenatal stress on pregnancy and human development: mechanisms and pathways.

Authors:  Mary E Coussons-Read
Journal:  Obstet Med       Date:  2013-05-03

Review 9.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

10.  Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth.

Authors:  Stacy Zamudio; Tatiana Torricos; Ewa Fik; Maria Oyala; Lourdes Echalar; Janet Pullockaran; Emily Tutino; Brittney Martin; Sonia Belliappa; Elfride Balanza; Nicholas P Illsley
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.